AMED Stock UPDATES Amedisys Inc (AMED) 25.22 10/29/2014 19:3

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Amedisys Inc (AMED) 25.22 $AMED

Nasdaq stocks posting largest percentage increases
AP - 2 hrs 29 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
IMDZ: 30.68 (+2.90), KONA: 21.55 (+2.17), BGFV: 12.03 (+1.23), RDCM: 8.95 (+2.74), TQNT: 20.20 (+1.77), AMED: 25.22 (+3.46), MRCY: 13.72 (+1.55)

Amedisys beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported net income of $8.4 million in its third quarter.
AMED: 25.22 (+3.46)

Amedisys Reports Third Quarter Financial Results
GlobeNewswire - Wed Oct 29, 6:00AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the three and nine-month periods ended September 30, 2014.
AMED: 25.22 (+3.46)

35.6% Return Seen to Date on SmarTrend Amedisys Call (AMED)
Comtex SmarTrend(R) - Tue Oct 28, 9:12AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 4 months, Amedisys has returned 35.58% as of today's recent price of $21.70.
AMED: 25.22 (+3.46)

5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Oct 27, 12:00PM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
KN: 19.22 (-0.18), RYAM: 28.39 (-1.94), CLF: 10.22 (-1.07), AMED: 25.22 (+3.46), LOCK: 15.31 (-0.79)

Quest Diagnostics Beats on Earnings & Revs, Ups View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 12:15PM CDT
Quest Diagnostics' (DGX) third-quarter 2014 adjusted earnings per share (EPS) from continuing operations came in at $1.10.
DGX: 63.68 (-0.06), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)

Uptrend Call Working As Amedisys Stock Rises 34.8% (AMED)
Comtex SmarTrend(R) - Mon Oct 20, 4:51PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 34.83% as of today's recent price of $21.58.
AMED: 25.22 (+3.46)

Amedisys Announces Third Quarter Earnings Release and Conference Call Date
GlobeNewswire - Thu Oct 16, 4:46PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the third quarter ended September 30, 2014 on Wednesday, October 29, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
AMED: 25.22 (+3.46)

Amedisys Has Returned 25.9% Since SmarTrend Recommendation (AMED)
Comtex SmarTrend(R) - Mon Oct 13, 11:00AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.00. In approximately 4 months, Amedisys has returned 25.90% as of today's recent price of $20.15.
AMED: 25.22 (+3.46)

Gentiva Awaits Acquisition; Inorganic Growth Compelling - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 8:50AM CDT
On Oct 10, 2014, we issued an updated research report on Gentiva Health Services, Inc. (GTIV).
KND: 21.22 (+0.16), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)

Gentiva Health Services (GTIV) Soars: Stock Rises 16.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 7:51AM CDT
Gentiva Health Services Inc. (GTIV) was a big mover last session, as the company shares rose almost 17% on the day.
USPH: 42.15 (+0.78), AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), GTIV: 19.55 (-0.03)

Walgreens' (WAG) September Sales Impress, Up 9.4% Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 06, 1:50PM CDT
Walgreen Co. (WAG) recently reported results for the month of Sep 2014.
ABAX: 49.64 (-0.37), CVS: 85.19 (-0.01), AMED: 25.22 (+3.46), WAG: 62.83 (-0.87)

Shares of AMED Up 27.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Sep 29, 9:11AM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 3 months, Amedisys has returned 27.52% as of today's recent price of $20.41.
AMED: 25.22 (+3.46)

Should Amedisys (AMED) Be in Your Portfolio Post Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 2:10PM CDT
On Sep 19, Zacks Investment Research upgraded Amedisys Inc. (AMED) to a Zacks Rank #1 (Strong Buy).
AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)

AmSurg Upbeat About Sheridan Acquisition Despite Poor Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 5:25PM CDT
On Sep 23, we issued an updated research report on AmSurg Corporation (AMSG) -- a leading operator of single-specialty practice-based ambulatory surgery centers (ASCs).
AMSG: 51.58 (+0.20), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10), GTIV: 19.55 (-0.03)

Five Star Quality Care (FVE) in Focus: Stock Gains 12.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 8:25AM CDT
Five Star Quality Care (FVE) was a big mover last session, with shares rising over 12% on the day.
FVE: 4.03 (+0.02), AFAM: 28.68 (+0.64), AMED: 25.22 (+3.46), HLS: 39.30 (+0.10)

Uptrend Call Working As Amedisys Stock Rises 26.9% (AMED)
Comtex SmarTrend(R) - Fri Sep 19, 4:49PM CDT
SmarTrend identified an Uptrend for Amedisys (NASDAQ:AMED) on June 27th, 2014 at $16.01. In approximately 3 months, Amedisys has returned 26.90% as of today's recent price of $20.31.
AMED: 25.22 (+3.46)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dahua's Pro Challenge 2026: Bridging Expertise Globally

Updated Category News Views 64

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...

Continue Reading
Data Center Transformers on the Brink of a Boom

Updated Category News Views 235

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Parallels Desktop: Top Dog for Windows on Mac

Updated Category News Views 75

A Simpler Way to Bridge the Mac and Windows World Seems like Parallels Desktop is once again flexing its muscles for Mac users in 2026. Expert Consumers out of New York just gave them the thumbs-up as the go-to pick for folks wanting to hitch their Mac wagon to Windows 11. And why not? Parallels lets you take a stroll through Windows land without cutting your Mac ties. A...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 46

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Greenworks Mower Snags Best Electric Award for 2026

Updated Category News Views 41

Greenworks Strikes Again with Top Lawn Mower Honors Man, when I think about the evolution from noisy, gas-guzzling lawn mowers to sleek, battery-powered beasts, Greenworks is right there, leading the charge. Just the other day, Popular Mechanics singled out the Greenworks 80V 22-inch Cordless Lawn Mower, handing it the coveted title of Best Electric Lawn Mower for 2026....

Continue Reading
ACME's AI Innovation Shakes Up Filmmaking Scene

Updated Category News Views 26

The Game-Changer in Virtual Production You ever hear about the Grey Box™ phenomenon? Sounds like a sci-fi gizmo, right? Turns out, it's the real deal and ACME Media's been riding this revolutionary wave straight to the top of the film industry ladder. Their approach with this AI-driven gizmo isn't just about cutting-edge tech wizardry—it's reimagining how we shoot...

Continue Reading
PangeAI and Sky Blue Transform Data Center Decisions

Updated Category News Views 80

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Continue Reading
Decoding Arrest: Steps from Arraignment to Trial

Updated Category News Views 71

Someone lands in handcuffs, and it's the start of a winding road through the justice system. We're talking about the stages you gotta navigate, explained by Criminal Law Attorney Tangi Carter. If you're anywhere near Hattiesburg, Mississippi, or quite frankly, have any eye on legal matters in your backyard, you know having a roadmap is pure gold. Arraignment: The...

Continue Reading
Millrose Faces Investor Deadline in Class Action Lawsuit

Updated Category News Views 75

Shakeup at Millrose Properties: Investor Alert! Alright, folks, gather around. We got a situation brewing with Millrose Properties, Inc. (NYSE: MRP) that's catching the attention of anyone who's hauled their portfolio through the storms and sunshine of the stock market. A class action lawsuit's knocking at the door, and any daydreaming investor who snatched up shares...

Continue Reading
AppLovin Faces Serious Investor Lawsuit Deadline

Updated Category News Views 72

Investors' Trust Shaken: The AppLovin Controversy Well, what do we have here? Another day, another hefty lawsuit coming down the pike. The spotlight’s on AppLovin Corporation (NASDAQ: APP), where the Hagens Berman law sharks are sniffing blood in the water over what they claim are federal securities law violations. The core of this legal storm swirls around AppLovin's...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Polymer Foam Market Trends and Insights for 2025-2034

Updated Category News Views 255

Understanding the Polymer Foam Market The polymer foam market has witnessed significant growth recently, with a valuation of USD 151.19 billion in 2024 and expectations of reaching USD 273.58 billion by 2034. This growth corresponds to a compound annual growth rate (CAGR) of 6.11% from 2025 to 2034. A substantial portion of this expansion is influenced by the increasing...

Continue Reading
Renee Gala Takes the Helm as Jazz Pharmaceuticals CEO

Updated Category News Views 249

Renee Gala Takes on Leadership at Jazz Pharmaceuticals In an exciting development for Jazz Pharmaceuticals, the Board of Directors has announced the unanimous selection of Renee Gala as the new President and Chief Executive Officer. This pivotal decision is set to take effect shortly, marking a significant transition for the company as it continues to forge its path in...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 58

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Fidelity National Financial Launches New Consent Solicitation

Updated Category News Views 304

Introduction to Consent Solicitation Fidelity National Financial, Inc. (NYSE: FNF) has recently announced the commencement of separate consent solicitations for its various series of Senior Notes, an initiative that aims to amend the terms of its existing indenture agreements. The company holds four series of Senior Notes—4.500% due in 2028, 3.400% due in 2030, 2.450%...

Continue Reading
Legal Insights on Hims & Hers Health, Inc. Class Action Case

Updated Category News Views 179

Understanding the Hims & Hers Health, Inc. Securities Litigation The legal landscape surrounding Hims & Hers Health, Inc. has become a focal point for investors as the recent securities fraud lawsuit unfolds. Investors have an opportunity to engage in this case, which may hold significant implications for their investments. Why This Lawsuit Matters This lawsuit,...

Continue Reading